Related references
Note: Only part of the references are listed.Immunotherapy: The Path to Win the War on Cancer?
CELL (2015)
Synthetic Nanoparticles for Vaccines and Immunotherapy
Darrell J. Irvine et al.
CHEMICAL REVIEWS (2015)
Tumor neoantigens: building a framework for personalized cancer immunotherapy
Matthew M. Gubin et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
The tyrosine kinase Itk suppresses CD8+ memory T cell development in response to bacterial infection
Fei Huang et al.
SCIENTIFIC REPORTS (2015)
Hydrogel Containing Nanoparticle-Stabilized Liposomes for Topical Antimicrobial Delivery
Weiwei Gao et al.
ACS NANO (2014)
Engineering vaccines and niches for immune modulation
Alberto Purwada et al.
ACTA BIOMATERIALIA (2014)
Hydrogels and Scaffolds for Immunomodulation
Ankur Singh et al.
ADVANCED MATERIALS (2014)
Endogenous lung surfactant inspired pH responsive nanovesicle aerosols: Pulmonary compatible and site-specific drug delivery in lung metastases
Nitin Joshi et al.
SCIENTIFIC REPORTS (2014)
Nanoengineered Particles for Enhanced Intra-Articular Retention and Delivery of Proteins
Ankur Singh et al.
ADVANCED HEALTHCARE MATERIALS (2014)
Understanding the biology of antigen cross-presentation for the design of vaccines against cancer
Cynthia M. Fehres et al.
FRONTIERS IN IMMUNOLOGY (2014)
Engineering synthetic vaccines using cues from natural immunity
Darrell J. Irvine et al.
NATURE MATERIALS (2013)
Applications of nanotechnology for immunology
Douglas M. Smith et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Raising the Bar: The Curative Potential of Human Cancer Immunotherapy
Steven A. Rosenberg
SCIENCE TRANSLATIONAL MEDICINE (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants
Latrisha K. Petersen et al.
BIOMATERIALS (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
New Therapies for Castration-Resistant Prostate Cancer.
Dan L. Longo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells
Ankur Singh et al.
BIOMATERIALS (2009)
Materials engineering for immunomodulation
Jeffrey A. Hubbell et al.
NATURE (2009)
Infection-mimicking materials to program dendritic cells in situ
Omar A. Ali et al.
NATURE MATERIALS (2009)
In Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in Mice
Omar A. Ali et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Efficient Modulation of T-cell Response by Dual-mode, Single-carrier Delivery of Cytokine-targeted siRNA and DNA Vaccine to Antigen-presenting Cells
Ankur Singh et al.
MOLECULAR THERAPY (2008)
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Sai T. Reddy et al.
NATURE BIOTECHNOLOGY (2007)
Targeting dendritic cells with biomaterials: developing the next generation of vaccines
Sai T. Reddy et al.
TRENDS IN IMMUNOLOGY (2006)
Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling
B Hahm et al.
IMMUNITY (2005)
Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells
MJ Turk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance
ZY Yu et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Cancer immunotherapy: A treatment for the masses
JN Blattman et al.
SCIENCE (2004)
Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo
P Kleindienst et al.
JOURNAL OF IMMUNOLOGY (2003)
Share Paper
